Barclays PLC Buys 71,024 Shares of Aspen Aerogels, Inc. (NYSE:ASPN)

Barclays PLC increased its stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 333.8% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 92,302 shares of the construction company’s stock after purchasing an additional 71,024 shares during the quarter. Barclays PLC owned 0.11% of Aspen Aerogels worth $2,557,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. FMR LLC increased its position in Aspen Aerogels by 23.6% during the third quarter. FMR LLC now owns 4,050,896 shares of the construction company’s stock valued at $112,169,000 after acquiring an additional 773,647 shares during the last quarter. Driehaus Capital Management LLC grew its holdings in Aspen Aerogels by 130.4% during the 2nd quarter. Driehaus Capital Management LLC now owns 2,156,789 shares of the construction company’s stock valued at $51,439,000 after purchasing an additional 1,220,724 shares during the last quarter. Loomis Sayles & Co. L P raised its position in Aspen Aerogels by 22.7% in the 3rd quarter. Loomis Sayles & Co. L P now owns 1,619,320 shares of the construction company’s stock worth $44,839,000 after purchasing an additional 300,076 shares during the period. State Street Corp raised its position in Aspen Aerogels by 0.6% in the 3rd quarter. State Street Corp now owns 1,410,543 shares of the construction company’s stock worth $39,058,000 after purchasing an additional 8,344 shares during the period. Finally, Dimensional Fund Advisors LP lifted its stake in Aspen Aerogels by 21.3% in the second quarter. Dimensional Fund Advisors LP now owns 1,374,631 shares of the construction company’s stock worth $32,790,000 after purchasing an additional 240,921 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Stock Performance

Shares of NYSE ASPN opened at $11.90 on Wednesday. The company has a 50 day simple moving average of $16.10 and a two-hundred day simple moving average of $22.15. The stock has a market cap of $976.36 million, a price-to-earnings ratio of 1,191.19 and a beta of 2.12. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. Aspen Aerogels, Inc. has a 12 month low of $10.75 and a 12 month high of $33.15.

Insider Activity at Aspen Aerogels

In related news, CEO Donald R. Young sold 63,355 shares of Aspen Aerogels stock in a transaction that occurred on Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the transaction, the chief executive officer now directly owns 483,640 shares in the company, valued at approximately $14,523,709.20. This trade represents a 11.58 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 4.30% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on ASPN shares. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a report on Wednesday, November 13th. Roth Mkm decreased their target price on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a research report on Friday, November 8th. Barclays lowered their price target on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a research report on Tuesday, November 12th. Piper Sandler lowered their price objective on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research report on Tuesday, October 22nd. Finally, HC Wainwright restated a “buy” rating and set a $30.00 target price on shares of Aspen Aerogels in a research note on Wednesday, October 16th. One research analyst has rated the stock with a sell rating, nine have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, Aspen Aerogels currently has an average rating of “Moderate Buy” and a consensus target price of $28.70.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.